What they were paid
ADC Therapeutics Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $62,500 | $143,600 | $0 | $0 | $206,100 |
| FY2024 | $62,500 | $126,400 | $0 | $827 | $189,727 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ADC Therapeutics SA DEF 14A filed April 20, 2026, accession 0001140361-26-015491, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025ADC Therapeutics pays directors a $45,000 cash retainer and $143,600 in RSUs.
Committees
FY2025 · as the proxy prints themNominating/Governance (Chair) · Science and Technology
The rest of the ADC Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Ameet Mallik | Director | $0 |
| Peter Hug | Lead Independent Director | $250,968 |
| Robert Azelby | Independent Director | $211,100 |
| Ron Squarer | Chair of the Board | $249,197 |
| Thomas Pfisterer | Independent Director | $37,001 |
| Timothy Coughlin | Independent Director | $431,129 |
| Tyrell J. Rivers | Independent Director | $0 |
| Victor Sandor | Independent Director | $211,100 |
| Viviane Monges | Independent Director | $246,414 |
The full ADC Therapeutics compensation record
free company briefThis page is one director within ADC Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat